- Home
- LNTH vs EXLS Comparison
LNTH vs EXLS Comparison
Compare LNTH & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- EXLS
- Stock Information
- Founded
- LNTH 1956
- EXLS 1999
- Country
- LNTH United States
- EXLS United States
- Employees
- LNTH N/A
- EXLS N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EXLS Business Services
- Sector
- LNTH Health Care
- EXLS Consumer Discretionary
- Exchange
- LNTH Nasdaq
- EXLS Nasdaq
- Market Cap
- LNTH 7.5B
- EXLS 7.0B
- IPO Year
- LNTH 2015
- EXLS 2006
- Fundamental
- Price
- LNTH $75.13
- EXLS $45.92
- Analyst Decision
- LNTH Strong Buy
- EXLS Strong Buy
- Analyst Count
- LNTH 5
- EXLS 7
- Target Price
- LNTH $133.80
- EXLS $50.29
- AVG Volume (30 Days)
- LNTH 1.5M
- EXLS 1.6M
- Earning Date
- LNTH 05-07-2025
- EXLS 04-29-2025
- Dividend Yield
- LNTH N/A
- EXLS N/A
- EPS Growth
- LNTH N/A
- EXLS 21.21
- EPS
- LNTH 3.53
- EXLS 1.32
- Revenue
- LNTH $1,536,699,000.00
- EXLS $1,902,884,000.00
- Revenue This Year
- LNTH $4.96
- EXLS $14.18
- Revenue Next Year
- LNTH $10.25
- EXLS $11.43
- P/E Ratio
- LNTH $21.28
- EXLS $34.83
- Revenue Growth
- LNTH 12.53
- EXLS 14.18
- 52 Week Low
- LNTH $75.00
- EXLS $28.59
- 52 Week High
- LNTH $126.89
- EXLS $52.43
- Technical
- Relative Strength Index (RSI)
- LNTH 27.24
- EXLS 49.76
- Support Level
- LNTH $77.01
- EXLS $45.65
- Resistance Level
- LNTH $81.50
- EXLS $46.48
- Average True Range (ATR)
- LNTH 3.52
- EXLS 1.00
- MACD
- LNTH -1.61
- EXLS 0.01
- Stochastic Oscillator
- LNTH 0.35
- EXLS 28.21
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.